In terms of the impact on the immune populations in the tumor microenvironment, mammary tumors from PyMT-RONΔMyeloid mice had increased numbers of F4/80 and iNOS positive cells and decreased Arginase-1 positive cells in the tumor TME compared to mammary tumors from PyMT control mice. This evidence concerns the gene NOS2 and breast cancer.